News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Mitchell Shawnte
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/21/2020 |
3
| Mitchell Shawnte (EVP, GC and Secretary) has filed a Form 3 on ZOGENIX, INC. |
| 04/21/2020 |
4
| Mitchell Shawnte (EVP, GC and Secretary) has filed a Form 4 on ZOGENIX, INC.|
Txns:
| Granted 110,000 options to buy
@ $26.68, valued at
$2.9M
|
|
| 03/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/04/2019 |
4
| Mitchell Shawnte (SVP, GC and Corporate Affairs) has filed a Form 4 on Aptevo Therapeutics Inc.|
Txns:
| Paid exercise price by delivering 2,012 shares
@ $1.57, valued at
$3.2k
Granted 67,400 options to buy
@ $1.52, valued at
$102.4k
Exercised 6,787 restricted stock units
@ $0 |
|
| 08/13/2018 |
4
| Mitchell Shawnte (SVP, GC and Corporate Affairs) has filed a Form 4 on Aptevo Therapeutics Inc.|
Txns:
| Paid exercise price by delivering 383 shares
@ $4.5, valued at
$1.7k
Exercised 1,630 restricted stock units
@ $0 |
|
| 08/10/2018 |
3
| Mitchell Shawnte (SVP, GC and Corporate Affairs) has filed a Form 3 on Aptevo Therapeutics Inc. |
|
|